Search
for
Sort by
Research 271–300 of 1000+
- ANTIANDROGENS AND THE SKIN
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Hyperandrogenismus, adrenale Dysfunktion und Hirsutismus
- Does maternal exposure to artificial food coloring additives increase oxidative stress in the skin of rats?
- Congenital Adrenal Hyperplasia
- Medical treatment regimens of hirsutism
- Sex Hormones and Antiandrogens Influence In Vitro Growth of Dermal Papilla Cells and Outer Root Sheath Keratinocytes of Human Hair Follicles.
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Ligand‐Independent Actions of the Vitamin D Receptor: More Questions Than Answers
- Female pattern hair loss
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Androgens and hair: a biological paradox
- What’s new in hidradenitis suppurativa?
- Alopecia - the search for novel agents continues
- Topical Antiandrogens
- Hydroxylation of dehydroepiandrosterone in human scalp hair folhcles
- Transcriptome sequencing and identification of cytochrome P450 monooxygenases involved in the biosynthesis of maslinic acid and corosolic acid in <i>Avicennia marina</i>
- Progestogens in menopausal hormone therapy
- Hirsutism
- A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia
- Endocrine systems of the skin
- Management of acne vulgaris with hormonal therapies in adult female patients
- Hyperandrogénie féminine
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Sex hormones and antiandrogens influence in vitro growth of dermal papilla cells and outer root sheath keratinocytes of human hair follicles
- Common Baldness in Women
- Osteoanabole Östrogentherapie bei einem transsexuellen Mann
- Treatment of hyperandrogenism in women
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro